Caitong International Asset Management Co., Ltd
Position in OCGN — Ocugen, Inc.
CIK 1963355
HONG KONG, K3
Position in OCGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$357,739
+$246,612 QoQ
Shares Held
197,646
+140.1% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caitong International Asset Management Co., Ltd holds $19,465,367 across 279 Biotechnology names. OCGN ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
55,071 | $2,797,606 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
180,980 | $1,312,105 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
64,980 | $1,271,008 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
112,937 | $1,017,562 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
18,173 | $893,384 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
33,197 | $775,481 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
16,222 | $548,790 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
17,783 | $530,822 |
All Filings in OCGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $357,739 | 197,646 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $111,127 | 82,317 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $174 | 107 | Shares | Sole | 2025-11-19 | |
| No filing history on record for this holder in this stock. | ||||||